On March 27, 2020, the U.S. Food and Drug Administration (FDA) approved durvalumab (Imfinzi®) in combination with etoposide and either carboplatin or cisplatin as first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC).
The Adjuvant Radiotherapy Intensification Classifier (ARTIC) predicts which women with early-stage breast cancer will benefit the most from radiotherapy, as well as their risk for locoregional recurrence after radiation, researchers reported in study findings published in the Journal of Clinical Oncology.
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in Latina women. Compared to all patients with breast cancer, Latinas are the second most common ethnic group to carry BRCA1 deleterious mutations, after Ashkenazi Jewish women.
Because of print production schedules, I prepared this article before the COVID-19 coronavirus arrived in the United States. The message would be different today: As you support your patients during the pandemic, know that ONS cares for you and has resources for you on our website and communities. We appreciate your leadership in providing quality cancer care every day. Thank you for all you do.
During its February 19–22, 2020, quarterly in-person meeting, the ONS Board of Directors established its 2020 health policy agenda, evaluated the Society’s member satisfaction, and collaborated with the Leadership Development Committee for a joint education session, among many other discussions and work.
Typically, African American men have worse outcomes from prostate cancer than their white counterparts. But according to the results of a new study in patients in the U.S. Department of Veterans Affairs (VA) health system where all patients have equal access to care, no disparities exist between the two groups—in fact, the African American men in the VA system had better outcomes than non-Hispanic whites. The findings were reported in Cancer.
Cancer is a global health problem. According to the American Cancer Society, cancer incidence is expected to continue to grow to nearly 27 million new cases around the world by 2040. In 134 of 183 countries, cancer is the first or second leading cause of premature death for people aged 30–69 years, and it ranks third or fourth in an additional 45 countries. Although cancer is a major health issue across the world, outcomes differ depending on a patient’s country of origin.
Many say that love is the universal language. I agree, but I’ve found that care is also universal.
Nurses and other healthcare providers on the front lines of the COVID-19 coronavirus pandemic are facing a shortage of personal protective equipment (PPE), including gloves, face shields, and N95 face masks. But grassroots efforts from citizens and companies are bringing PPE donations or funneling supplies from donors to medical facilities in response to pleas from the healthcare community.
When referring patients for genetics counseling and possible testing for hereditary risk, oncology nurses can help relieve their trepidation and anxiety by explaining what to expect during the visit. See the sidebar for key indications for referral.